INTRODUCTION
More than 45,000 Canadians suffer OHCA annually, with only 8.4% surviving to hospital discharge.Reference Nichol, Thomas and Callaway 1 , 2 Current treatment strategies for OHCA focus on high quality cardiopulmonary resuscitation (CPR), early rhythm identification, and defibrillation for shockable rhythms such as ventricular fibrillation (VF) or pulseless ventricular tachycardia (pVT).Reference Link, Berkow and Kudenchuk 3
Unfortunately, a proportion of patients with VF does not respond to standard therapy and succumb to VF, despite multiple defibrillation attempts. The definition of shock RVF varies in published literature. In the recent Resuscitation Outcomes Consortium – Amiodarone, Lidocaine, or Placebo Study (ROC-ALPS), of 37,889 patients with non-traumatic OHCA considered for enrolment, 18.6% had shock RVF or pVT, defined as refractory to at least one shock by emergency medical services (EMS) personnel.Reference Kudenchuk, Brown and Daya 4 Sakai et al. found the incidence of VF that was resistant to at least one shock by EMS has an incidence of 0.5-0.6 cases per 100,000.Reference Sakai, Iwami and Tasaki 5 Others have defined RVF as VF that has not responded to five defibrillation attempts at standard energy with ongoing high quality advanced cardiovascular life support (ACLS) care.Reference Cabañas, Myers and Williams 6 - Reference Leacock 8 Patients with RVF have dismal outcomes because there are no well-established treatment options available.Reference Sakai, Iwami and Tasaki 5 , Reference Sarkozy and Dorian 7 Recently, a small study of esmolol administration during VF refractory to at least three shocks demonstrated some success increasing the rate of return of spontaneous circulation (ROSC); however, the improvement in the rate of neurologically intact survival was not statistically significant.Reference Lee, Lee and Min 9 Some jurisdictions use mechanical CPR, extracorporeal membrane oxygenation (ECMO) assisted resuscitation, or early percutaneous coronary intervention (PCI) during VF, but these interventions are not routine in most emergency departments and not readily achievable outside of large urban centres.
DSED involves the use of two defibrillators and two sets of defibrillator pads (Figure 1). As soon as the two sets of pads are applied to the patient, both defibrillators are discharged nearly simultaneously. DSED has been described and studied in the electrophysiology suite for the treatment of refractory arrhythmiasReference Hoch, Batsford and Greenberg 10 - Reference Alaeddini, Feng and Feghali 12 but has not translated into mainstream medical care for OHCA.
We present a case of successful use of DSED in our Canadian emergency department for a patient with RVF. Consent was obtained from the patient to publish the details of his case in accordance with guidelines set out by the Queen’s University Health Sciences Research Ethics Board (File number: 6018904).
CASE
A 53-year-old male with a previous history of osteoarthritis, psoriasis, and hypertension (treated with ramipril) developed chest pain and nausea while cleaning out his garage. A 911 call was made, and a primary care paramedic crew arrived at 1136 hours to find an overweight (body mass index [BMI] 28.4), pale, and diaphoretic patient who was complaining of ongoing 4/10 chest heaviness radiating to his back and left arm, with a pulse of 106 and an indeterminate blood pressure. The patient reported a similar episode of chest pain 4 days prior that had resolved spontaneously. Acetylsalicylic acid (ASA) 160 mg was administered, but, prior to initiation of transport at 1139 hours, the patient developed VF. He was immediately defibrillated using a Zoll X series defibrillator and a biphasic shock of 200 joules (J). The defibrillator pads were placed in the standard anterolateral configuration. He regained consciousness within seconds, with a subsequent pulse of 84 and blood pressure of 110/66 mm Hg.
An on-scene 12-lead electrocardiogram (ECG) demonstrated sinus rhythm and 4 mm of ST-segment elevation in V1-V3 (Figure 2, A ). The local ST-elevation myocardial infarction protocol was activated at 1152 hours, and transport to the regional PCI centre commenced.
At 1159, while still en route, a second episode of VF occurred (see Figure 2, B ), this time refractory to two defibrillation attempts at 200 J, chest compression, and bag-valve-mask (BVM) ventilation by paramedics.
On arrival in the emergency department at 1205 hours, the patient had no vital signs and continued to be in VF. A third attempt at defibrillation with 200 J was made prior to transfer onto the emergency department stretcher and was unsuccessful. Intravenous access was obtained and tenecteplase 50 mg, amiodarone 300 mg, and epinephrine 1 mg intravenous were administered to maximize the probability of myocardial reperfusion given the presumed cardiac etiology of his cardiac arrest. A fourth defibrillation attempt using a biphasic Lifepak 20 at 200 J with the traditional anterolateral pad placement was performed shortly thereafter and was also unsuccessful. The patient was intubated with paralytic assistance during ongoing CPR using direct laryngoscopy, and the decision was made to attempt DSED. A second Lifepak 15 defibrillator was applied in an anteroposterior position and two providers, each operating one defibrillator, delivered near simultaneous 200 J biphasic shocks at 1216 hours. The patient was successfully defibrillated into a narrow complex bradycardia and had a palpable pulse at 1218 hours.
Within 60 seconds, VF recurred. A second DSED attempt at 200 J from each defibrillator at 1222 hours successfully defibrillated the patient back to sinus rhythm with a heart rate of 53/minute, blood pressure of 115/97 mm Hg, and Glasgow Coma Scale of 3T. Emergency department 12-lead ECG demonstrated ST elevation in V1-V3 with reciprocal changes (see Figure 2, C ), and the patient was transferred to the angiography suite at 1314 hours on a norepinephrine infusion to help maintain blood pressure. He underwent percutaneous coronary angioplasty with stenting of two lesions in the left anterior descending (LAD) (99% and 70% stenosis). An intra-aortic balloon pump was inserted at the time of angioplasty and removed within 48 hours as his vasopressor requirements decreased. His maximum high-sensitivity troponin I was >50000 ng/ml.
During post-arresttargeted temperature management (target of 32°C–34°C), the patient developed persistent hyperglycemia that was treated with insulin leading to severe hypokalemia (1.5 mmol/L), and another cardiac arrest that occurred approximately 24 hours after his hospital arrival. Standard ACLS care with traditional single defibrillator shocks and intravenous potassium were used with success. He later developed a ventilator-associated pneumonia on post-admission Day 3 and episodes of delirium. He was discharged home on post-admission Day 14 neurologically intact with a cerebral performance category score of 1.
DISCUSSION
Background
We present a case of successful resuscitation using DSED in the emergency department setting for RVF in an EMS-witnessed cardiac arrest secondary to ST-elevation myocardial infarction.
DSED has been previously reported to work for multiple etiologies of cardiac arrest.Reference Cabañas, Myers and Williams 6 , Reference Leacock 8 , Reference Hoch, Batsford and Greenberg 10 - Reference Johnston, Cheskes and Ross 16 In one report of 2,990 consecutive patients undergoing treatment in the electrophysiology lab over a 3-year period, all 5 patients with VF refractory to standard defibrillation were successfully defibrillated with DSED.Reference Hoch, Batsford and Greenberg 10
A handful of prehospital and emergency department case reports and small case series in recent years describe DSED.Reference Cabañas, Myers and Williams 6 , Reference Leacock 8 , Reference Lybeck, Moy and Tan 14 - Reference Johnston, Cheskes and Ross 16 In one prehospital OHCA case series, with 10 patients, DSED converted RVF to an alternate rhythm with or without perfusion in 7 of 10 OHCA, although no patients survived to hospital discharge.Reference Cabañas, Myers and Williams 6 A retrospective observational single centre study evaluating neurologically intact survival in OHCA patients with refractory or recurrent VF treated with DSED versus conventional therapy did not detect a statistically significant difference in the primary outcome of neurologically intact survival to hospital discharge.Reference Ross, Redman and Harper 17 Three of 50 patients in the DSED group survived to discharge neurologically intact compared to 26 of 229 standard therapy patients.Reference Ross, Redman and Harper 17 Important prognostic characteristics, such as bystander CPR and whether the arrest was witnessed, differed between the two groups, and there was no measure of the quality of CPR or record of when DSED was used during the cardiac arrest.
In the reports, authors suggest that DSED may have been used too late in the majority of resuscitations. Yet using DSED too soon makes it difficult to establish superior efficacy over conventional defibrillation because a subsequent shock may have been successful whether it was a DSED. In our case, DSED was attempted approximately 18 minutes after collapse and after four failed defibrillations with sustained ROSC achieved at 27 minutes.
Proposed mechanisms
Three mechanisms for DSED efficacy have been proposed: vector, total energy, and timing.
Vector theory
Vector has emerged as the most popular proposed mechanism for DSED. It is theorized that initial pad placement may not provide the correct energy vector, and thus a second shock from a second vector may be the key to success.Reference Cabañas, Myers and Williams 6 Although external pad placement determines the overall vector of the energy discharge, anatomic variation and slight differences in pad placement may greatly change the current density traversing the ventricles. Gerstein has shown that delivery of current from multiple vectors is superior to a single vector when treating arrhythmias.Reference Gerstein, Shah and Jorgensen 13 It is theorized that shock vectors aligned with the ventricular septum have a higher success rate.Reference Gerstein, Shah and Jorgensen 13 Thus, two distinct and nearly orthogonal energy vectors increase the probability of optimal orientation to the interventricular septum.Reference Gerstein, Shah and Jorgensen 13 , Reference Kerber, Spencer and Kallok 18 For example, Jones et al. have suggested that certain areas of myocardium receive lower current densities than others when an electrical pulse is passed between two poles (one set of pads), rather than when four poles are used (two sets of pads).Reference Jones, Klein and Kallok 19 See Figure 3 for a visual representation. Theoretically, repositioning pads when treating RVF using a single defibrillator may be as effective as DSED. On the basis of insufficient higher-level evidence, ILCOR has yet to update its treatment recommendations on pad placement or energy level from the 2010 recommendations.Reference Morrison, Deakin and Morley 20
Timing theory
Another proposed mechanism of DSED relates to the timing of the energy release. In DSED, the defibrillators discharge asynchronously, thereby prolonging the duration of defibrillation and the flow of current through the fibrillating myocardium. This is thought to increase the chance of successful defibrillation.Reference Gerstein, Shah and Jorgensen 13 , Reference Lybeck, Moy and Tan 14 Human studies have shown that multiple sequential shocks decrease the threshold for defibrillation.Reference Jones, Klein and Guiraudon 21 Using canines, Johnson et al. varied the time between shocks in DSED to determine the optimal timing separation of shocks.Reference Johnson, Alferness and Wolf 22 Shocks in rapid succession of either <10 msec or >75 msec and <125 msec have a higher chance of success.Reference Johnson, Alferness and Wolf 22 In contrast, shocks around the refractory period at approximately 50 msec have a lower probability of success, requiring a substantially higher voltage to convert VF into a perfusing rhythm.Reference Johnson, Alferness and Wolf 22 Johnson et al. also found that two shocks separated by the 75-125 msec period, successfully defibrillated dogs at an energy level that would have failed to defibrillate the myocardium after a single shock.Reference Johnson, Alferness and Wolf 22 The current, somewhat naïve practice of attempting to synchronize two shocks using separate defibrillators leads to the shocks being delivered at slightly different times. Ensuring that the interval between the shocks actually falls within the optimal time range that would maximize the chance for successful defibrillation will require modification of the existing technology.
Total energy theory
Finally, the total energy delivered to the myocardium may contribute to the success of DSED. A second defibrillator discharging nearly simultaneously with the first may increase the intracardiac voltage gradient above the threshold required to terminate VF. Zhang et al. suggest that body habitus has a large role to play in external defibrillation success.23 In a swine model, this group demonstrated that a larger BMI would require a higher biphasic energy level to obtain the appropriate current to eliminate VF.23 Energy levels of up to 720 J (360 J × 2) have been used for DSED; this total energy delivered may be partly responsible for its success, especially in larger patients.Reference Hoch, Batsford and Greenberg 10
CONCLUSION
Recent reports of anecdotal success with DSED support the biologic rationale, feasibility, and potential efficacy of DSED for treatment of RVF. DSED should be evaluated with a well-designed randomized controlled trial to determine the optimal configuration of electrical defibrillation for VF.
Acknowledgement
The authors would like to thank Dr. Marco Sivilotti for his help with proofreading this manuscript.
Competing interests: None declared.